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The aim of this retrospective study was to highlight the imaging findings of groove pancre-
atitis (GP) as well as its management.
Patients and methods: 16 patients diagnosed to have GP were enrolled in this work. The
included patients had complete records of the thorough clinical examination and labora-
tory workup. All patients had been examined by multi-phase contrast enhanced MDCT tai-
lored for pancreatic imaging. Six of these patients were additionally examined by MRI
including MRCP.,
Results: MDCT Multiple detector computed tomography of the 16 patients revealedthe
following: (1) a hypodense sheet in the pancreaticoduodenal (PD) groove seen in 12
patients with mild enhancement in the delayed phase seen in 6 of the them; (2)
Duodenal wall thickening was seen in 10 patients while (3) associated cysts within the
duodenal wall or in PD groove were seen in 6 patients; (4) and pancreatic head enlarge-
ment in 8 patients. MRI of Six patients revealedthe following: (1) a T1 hypointense and
T2 iso to hyperintense sheet at the PD groove in 4 patients with delayed enhancement
in 3 of them; (2) Duodenal wall thickening with T2 high signal was seen in 6 patients while
associated cysts within the duodenal wall were seen in 4 patients; (3) Pancreatic head
enlargement seen in 4 patients; The MRCP of these patients showed dilated CBD with distal
tapering and a distance separating its end from the duodenal wall.
Conclusion: GP is a disease that should be considered in the list of differential diagnosis of
masses implicating the pancreatic head and medial duodenal wall. Imaging findings that
are suggestive of GP include chronic inflammatory changes with fibrosis in the PD groove
with or without implication of the nearby head of the pancreas, duodenal medial mural
thickening with luminal stenosis and cysts at the PD groove or within the duodenal wall.
Vascular invasion is a sign against diagnosis of GP.
 2016 The Egyptian Society of Radiology and Nuclear Medicine. Production and hosting by
Elsevier. This is an open access article under the CC BY-NC-ND license (http://creativecom-
mons.org/licenses/by-nc-nd/4.0/).1. Introduction
The pancreaticoduodenal (PD) groove is a potential
space located between the head of the pancreas medially,
second part of duodenum laterally, third part of duodenum
and inferior vena cava posteriorly and the first part of the
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nodes, portion of the common bile duct, distal main pan-
creatic duct, distal accessory pancreatic duct as well as
the major minor papilla. Small vessels are passing within
this space, and the most important of these is the superior
PD artery [1].
Groove pancreatitis (GP) is a specific type of pancreati-
tis originating in the PD groove. Sometime it involves the
nearby head of the pancreas, second part of the duodenum
and the common bile duct [2,3].
Several different terms have been used to describe this
inflammatory processes centered in the PD groove, includ-
ing groove pancreatitis, periampullary duodenal wall cyst,
myoadenomatosis, and cystic dystrophy of the duodenal
wall. These disorders have clinically been grouped together
and are termed ‘‘paraduodenal pancreatitis” [4]. Paraduo-
denal pancreatitis was first described by Becker in 1973
then Stolte et al. [2] introduced the term ‘‘groove pancre-
atitis” for the same condition which is more used in the
literature.
The incidence of GP was reported in three different ser-
ies of pancreaticoduodenectomy in patients with chronic
pancreatitis, which was different. The percentage of occur-
rence was 2.7%, 19.5% and 24.5% in the three different ser-
ies respectively [2,5].
Patients affected by GP are usually adult males with
alcohol abuse while GP has been described in females spo-
radically [6].2. Aim of the work
The purpose of this study was to describe the imaging
findings of GP as well as its management.
2.1. Patients
16 patients with a diagnosis of GP were enrolled in this
study. They included 12 males and 4 females, and their
ages ranged between 35 and 73 years with the mean age
of 58 years. Inclusion criteria include those patients with
the final diagnosis of GP while those with the final diagno-
sis of pancreatic groove carcinoma, peptic ulcer disease,
duodenal cancer, ampullary cancer or pancreatic head can-
cer were excluded.
2.2. Methods
This study is a retrospective study where patient con-
sent was waived by the Research Ethics Board, assuring
respect of the confidentiality of the medical record. We
have reviewed our medical records for the diagnosis of
GP during the period between January 2011 and October
2015.
The included patients had complete records of the thor-
ough clinical examination, laboratory workup including
routine laboratory work as well as lipase, amylase CEA
and CA19.9. All patients had been examined by multi-
phase contrast enhanced MDCT tailored for pancreatic
imaging including non-contrast, pancreatic, portal and
delayed phases. The machine used was Toshiba Aquilion128-MDCT unit kV/effective mAs/rotation time
(s):120 kV/225 eff. mAs/0.35 s; slice thickness 0.5 mm.
Non-ionic IV contrast was injected with a dose of
1.5 ml/kg (maximum = 150 ml), with average rate of
4 ml/s using automatic pump injector.
The pancreatic phase timing was fixed at 45 s, portal
phase at 70 s, and delayed phase after 5 min from the start
of contrast injection respectively, and examination was
done using Siemens Emotion 6 and 64 MSCT. Scanning
parameters were as follows: Volumetric High-spatial-
frequency kernel algorithm; Slice thickness: 1–1.25 mm;
Table speed for volumetric HRCT to enable the least cycles
of breath-holds as possible; Tube rotation: 0.6–0.9 s (mean
0.75 s); Detector Collimation 1 mm; Helical mode (volu-
metric HRCT); and kVp and mA per slice: 120–130 kVp
and 200–400 mA, according to weight of the patient and
clinical indication.
Six of these patients were additionally examined by
MRI including MRCP, using a 1.5 T closed MRI imager
(Avanto, Siemens, Erlangen, Germany). The pulse
sequences used were transverse T2FSE with and without
fat saturation, T1 chemical shift sequences (In/opposed
phase), Dynamic pre- and post Gadolinium Volumetric
Interpolated Breath-Hold Examination (VIBE) sequences,
and MRCP sequences (thin slice 3D, as well as thick slab
single shot).
Scanning parameters are as follows:
 Localizing T1-W gradient echo sequences were used.
 Axial 2D T2-W turbo spin echo (HASTE/TSE) fat sup-
pression sequence from the level of lower chest to
mid abdomen level as finishing the whole liver span.
TR1600, TE 70, flip angle 90, FOV 375, slice thickness
7 mm, NSA 1 total scan time averaging 43 s.
 Axial 2D T2-W turbo spin echo (HASTE/TSE) fat sup-
pression sequence with longer TE = 190. It was impor-
tant to diagnose the degree of signal intensity of the
lesion in long TE.
 In-phase and opposed phase (IP/OP) sequence TR 500,
TE in-phase (2.2), TE opposed phase (4.4) FOV 375, flip
angle 80, slice thickness 7 mm, NSA 2, average scanning
time 48 s. It was important in diagnosis of lesions con-
taining intracellular fat as well as in diagnosis of focal or
patchy fatty infiltration or sparing.
 SSFP (BFFE in Philips) TR500, TE60, flip angle 60,
FOV255, slice thickness 7 mm, NSA 1 with average scan
time 22 s.
 DWI with variable b values 50–1000 s/mm2 with TR
1000, TE 137, flip angle 90, FOV 370, slice thickness
10 mm and average scan time 1.15 min. and automati-
cally computer-generated ADC map.
 3D T1 spoiled gradient fat-suppressed sequence with TR
50, TE 500, FOV 355, flip angle 10, slice thickness 3 mm
with average scan time 19 s and this is repeated in
triphasic study as HAP (15 s after the end of contrast
injection), PVP (70 s from the end of contrast injection)
and delayed phase (about 3 min from the end of con-
trast injection).
MRCP examinations were obtained with a single-shot,
heavy T2W FSE sequence, HASTE (Siemens) by using respi-
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image acquisition during brief breath hold and even it is
so fast that allows imaging in patients who cannot hold
breath efficiently. This sequence includes the following:
 Thin section multisections moderate T2W FSE
sequence: A TR of 1600 ms, an echo time (TE) of
290 ms, a slice thickness = 2 mm, FOV = 380, aver-
age = 2.0, flip angle, 140, matrix size = 412  576 and
turbo factor = 109.
 Thin section multisections heavy T2W FSE sequence: A
TR of 2900 ms, an echo time (TE) of 700 ms, a slice
thickness = 1 mm, FOV = 380, matrix size = 357  384
average = 2.0, flip angle, 140, and turbo factor = 135.
 A two dimensional thick single slab projectional image:
A repetition time (TR) of 4500 ms, an echo time (TE) of
700 ms, a slice thickness = 40 mm, distant factor = 50%,
Field of view (FOV) = 350 mm, matrix size = 307  384,
average = 1.0, flip angle, 180 and turbo factor = 256.
The MIP images generated from the entire volume of a
thin section multisection data set resemble ERCP
images or thick slab images.
The management of patients with GP was either conser-
vative in 6 patients or surgical with Whipple procedure in
10 patients. Satisfactory improvement of the symptoms
was noted in 4 out of 6 with conservative management
and 7 patients with surgical management. The diagnosis
was confirmed by histopathology in 12 patients (10 surgi-
cal specimens and 2 FNAC), while clinical improvement
and follow-up CT confirmed the diagnosis in the other 4
patients.
The MRI and CT scans were analyzed to highlight imag-
ing features of groove pancreatitis.3. Results
3.1. Clinical picture (Table 1)
The patients presented with variable clinical pictures
including epigastric pain in 10 patients, obstructive jaun-
dice in 8 patients, vomiting in 8 patients, weight loss in 6
patients, and diarrhea in 4 patients. Some of the patients
presented with more than one of above. Mild elevation of
amylase and lipase was reported in 8 and 6 patients
respectively while elevated indirect bilirubin was reported
in 8 patients. None of the patients showed significant rise
of the CEA, CA19.9 or other tumor markers.Table 1
Summary of the different positive and negative CT findings among the 16
patients.
Clinical picture Number of patients
Epigastric pain referred to the back 10
Vomiting 8
Jaundice 8
Weight loss 6
Diarrhea 4
NB some patients may have more than one of the above.3.2. Multiple findings were seen on the MDCT examinations of
the 16 patients (Table 2) including
(1) A hypodense sheet at the PD groove was seen in 12
patients with modest enhancement identified in delayed
phase seen in 6 of the them. (2) Duodenal wall thickening
was seen in 10 patients while associated cysts within the
duodenal wall or in PD groove were seen in 6 patients.
(3) Pancreatic head enlargement with diffuse enhance-
ment was seen in 8 patients. (4) Mild pancreatic duct
dilatation was seen in 8 patients while dilatation of the
CBD was seen in 10 patients with distal tapering and
intra-hepatic biliary dilatation. (5) None of the patients
showed peri-pancreatic fluid collections, vascular invasion
or occlusion, ascites, locoregional suspicious nodes or
other stigmata of intra abdominal metastatic disease. None
of our cases showed distended GB (Figs. 1–3).3.3. Six patients out of the above described 16 patients had
MRI as well (Table 2), showing the following
(1) A T1 low signal and T2 iso to hyperintense signal
sheet at the PD groove was seen in 4 patients with delayed
enhancement in 3 of them. (2) Duodenal wall thickening
with T2 high signal was seen in 6 patients while associated
cysts of T2 fluid signal within the duodenal wall were seen
in 4 patients. (3) Pancreatic head enlargement with low T1
signal alteration was seen in 4 patients. (4) Mild pancreatic
duct dilatation was seen in 4 patients with pancreatic body
and tail atrophy in 2 of them while dilatation of the CBD
was seen in 4 patients with distal tapering and intra-
hepatic biliary dilatation. (5) None of the patients showed
peri-pancreatic fluid collections, ascites, loco-regional sus-
picious nodes or other stigmata of intra abdominal meta-
static disease (Figs. 2 and 4).
The MRCP of these patients showed dilated CBD with
distal tapering and a distance separating its end from the
duodenal wall in addition to fluid filled cysts at the duode-
nal wall (Figs. 2 and 4) seen in 4 patients while the other 2
patients had almost unremarkable MRCP.4. Discussion
GP has two types: pure type or form that affects exclu-
sively the PD groove with sparing of the pancreatic head
and segmental type which is epicentered in groove with
extension medially into the head of the pancreas. The dif-
ferentiation between these two forms is not usually clear
[7,2].
In our study pure form of the disease was seen in CT
examinations in 8 cases (50%) presenting with, the classic
findings of a hypo-dense sheet like soft tissue density
within the PD groove. Four of these showed retained con-
trast represented by enhancement in the delayed phase
representing fibrous tissue. This delayed enhancement is
explained by hindered blood flow caused by fibrous tissue
growth impeding the arterial flow due to arterial constric-
tions [8].
The GP segmental type was seen in the other 8 patients
(50%) where the sheet like focal hypodense lesions
Fig. 1. Multiphase MDCT; Axial (A and B) in the porto-venous phase,
showing ill defined sheet of hypodensity at the duodeno-pancreatic
groove which showed delayed enhancement in delayed phase (C)
(arrows). The medial wall of the second part duodenum is thickened
(asterisk). Pure form of groove pancreatitis.
1178 A. E.-A. M. El-Nekidy et al. / The Egyptian Journal of Radiology and Nuclear Medicine 47 (2016) 1175–1184extended into the pancreatic head in vicinity of the duode-
nal wall with pancreatic head enlargement.
Similar findings were reported in previous studies with
emphasis on the coronal reconstructions of MDCT data thatcan allow better identification of ill-defined fat stranding
and inflammatory changes in the PD groove accompanied
with increasing delayed enhancement as a result of a sig-
nificant fibrotic component [9].
The pure form is rather easy to identify. On the other
hand, the segmental form can be difficult to diagnose,
because involvement of the groove is often obscured by
mass like involvement of the pancreatic head. The segmen-
tal type of GP is confused for a pancreatic head mass, and
differentiating the two entities is not easy on the MRI
and CT [10,11].
The main pancreatic ducts showed mild dilatation in
seen at the body and tail of the pancreas in the 8 cases with
segmental type, while in the pure form of GP the main pan-
creatic ducts were not dilated. It is also reported that pan-
creatic duct can also be narrowed toward the head of the
pancreas in a smooth gradual pattern. In more chronic
stage, pancreatic parenchymal changes resembling those
of ordinary chronic pancreatitis can develop including pan-
creatic calcifications, ductal dilatation, and ductal beading
or irregularity [9,11].
Other important findings were also noted in our series
including focal duodenal wall thickening seen in 10 cases
(62.5%) and cysts in the duodenal wall itself or in groove
between the pancreatic head and the duodenum in 6 cases
(37.5%). The cysts were variable in size and number rang-
ing from tiny to large even multi-locular cystic mass like
lesion was seen in a single case. Appreciating medial duo-
denal wall thickening is easier also on the coronal images
[8].
Other authors found that these multiple cysts suggest
cystic dystrophy in heterotopic pancreatic islands within
the duodenal wall. They also claimed that heterotopic pan-
creatic tissues could not be identified on CT until they got
inflamed with cystic changes [12].
The pathology of GP in the literature addressed that the
duodenal mucosa between the major and minor papillae is
markedly thickened. The involved areas show gelatinous
contents, edema and fibrosis with possible cyst formation.
The cysts may contain small calculi. Microscopic evalua-
tion reveals duodenal wall thickening, with glandular and
muscular inflammation and hyperplasia. Sometimes pan-
creatic islands heterotopia can be seen. The scarring impli-
cates the lower portion of the common bile duct in the PD
groove [13–16].
The origin of the cysts in GP is controversial, and the
most popular theory claims that they are cystic dystrophy
of the pancreatic heterotopic islands in the duodenal wall
[17]. Other authors suggested that these cysts may be
dilated Santorini duct branches [18].
The cause of GP is still controversial including coexist-
ing biliary disorder, gastric ulcers, and heterotopic pancre-
atic tissues or disturbed pancreatic fluid flow through the
duct of Santorini [2,5]. The specific location of the lesions
around the minor papilla suggests possible anatomical or
functional disorder related to this area as GP may occur
in cases with pancreas divisum, absent or narrow duct of
Santorini [19], or may be due to obstruction of the acces-
sory pancreatic duct [17,19].
An important point noticed in our series and reported
previously, is that even in severe GP, the surrounding ves-
Fig. 2. Multiphase MDCT Axial (A and B) in late arterial phase, showing ill defined sheet of hypodensity at the duodeno-pancreatic groove with partial
extension into the pancreatic head. The corresponding Axial T2 WI (C&D) done two weeks later showed similar sheet of tissues expressing mild T2
hyperintense signal as well as mild duodenal wall thickening and enlarged pancreatic head. Coronal single shot MIP (E), showing the intra and extra-hepatic
biliary dilatation with distal tapering of the CBD as well as a relatively gapping distance between its end and the 2nd part of the duodenum. Tiny cystic
changes in the duodenal wall seen (C&E). Segmental form of groove pancreatitis.
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Also in our series we have not detected CT signs of acute
pancreatitis or loco regional metastasis or adenopathies.
The previous studies reported rarity to visualize fluid in
the para-renal spaces or surrounding the pancreas [10,11].
In our study CBD dilatation and distal smooth tapering
were seen in 10 patients (62.5%) including all the segmen-
tal types and 2 of the pure type leading to intra- and extra-
hepatic biliary system dilatation.
Previous studies also found that distal common bile
duct can appear attenuated and narrowed in both pure
and segmental types of GP. This was better assessed on
the coronal multiplanar reconstruction (MPR).In most cases, this narrowing was relatively smooth,
tapered, and regular, without evidence of shouldering or
irregularity [9,11].
As a fact, CT provides superior spatial resolution, but
with less contrast resolution to discriminate pancreatic
cancer from inflammation. The high soft-tissue resolution
of MRI provides more accurate evaluation of the pancreatic
tissues, specifically for tissue characterization in inflamma-
tory and neoplastic processes and analysis of contents of
cysts [21–24].
MRI and MRCP were available in 6 patients in our study.
There was a CT similarity regarding the sheet of tissues
within the pancreaticoduodenal groove. These were seen
Fig. 3. Multiphase MDCT; Axial (A) and Coronal (B) porto-venous phase,
showing ill defined sheet of hypodensity; coupled with cystic changes at
the duodeno-pancreatic groove. The medial wall of the second part
duodenum is thickened. Partial extension to the pancreatic head. Mild
segmental form of groove pancreatitis.
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signal in 3 patients with depiction of mild enhancement
in the delayed phases in three of them (50%). These cases
represented the pure type of GP, while in the segmental
form there was associated pancreatic head enlargement
in the other 3 patients.
Involvement of the pancreas was reported to be well
visualized on MRI compared to CT, with progressive lossTable 2
Summary of the different positive and negative CT and MRI findings among the p
CT MRI
Finding No. patients % Findi
Hypodense sheet 12 75 Hypo
Duodenal wall thickening 10 62.5 Duod
CBD dilatation and distal tapering 10 62.5 CBD
Pancreatic head enlargement 8 50 Pancr
Pancreatic duct dilatation 8 50 Pancr
Delayed enhancement 6 37.5 Delay
Duodenal cysts 6 37.5 Duod
Collections and stranded mesentery 0 0 Colle
Locoregional lymph nodes 0 0 Locor
Intra-abdominal metastasis 0 0 Intra
Vascular invasion 0 0 Vascu
GB distension 0 0 GB dof T1 signal intensity in the head of the pancreas as a result
of parenchymal atrophy and fibrosis [25,26].
Irie et al. [7] and Blasblag et al. [26] also reported sim-
ilar MRI findings in GP explaining the T2 iso to hyperin-
tense signal variation of the lesion in the PD groove or in
the head of the pancreas head to match with stage of the
disease, as the subacute phase disease shows higher T2 sig-
nal due to edema, and chronic phase has darker T2 signal
due to evolution of fibrosis.
Duodenal wall thickening was seen in the MRI of all the
6 patients with 4 of them showing mural cysts. The medial
wall of duodenum is involved in the pure as well as the
segmental forms of GP, with multiple T2 hyperintense
cysts in both the duodenal wall and PD groove.
Blasblag et al. [26] described similar changes in their
study. Also they described peripheral enhancement in the
pancreatic and portal phases with progressive fill in the
delayed phases. This delayed enhancement was reported
also in the related thickened medial wall of the duodenum.
This delayed enhancement reflects presence of fibrosis
[25].
In our study pancreatic head enlargement with low T1
signal alteration was seen in 4 patients with pancreatic
duct dilatation in addition to atrophy of the rest of pan-
creas. This reflects chronic inflammatory disease with
fibrous tissues replacing the glandular tissues of the pan-
creas. In the pure type of GP, the pancreas appears normal
and shows relatively high T1 signal [26].
In our study duodenal wall thickening with T2 high sig-
nal was seen in 6 patients while associated small cysts of
T2 fluid signal within the duodenal wall were seen in 4
patients. MRCP facilitates determination of relationship
between these cysts and CBD and pancreatic ducts [26].
Marked duodenal wall thickening is usually not associ-
ated with pancreatic neoplastic processes while it is com-
mon in GP [26]. This sign can help in differentiating GP
from pancreatic cancers.
In our study MRCP was available in 6 patients, showing
dilated CBD with distal tapering with a distance separating
distal ends from the duodenal walls, fluid filled cysts at the
duodenal wall or in the groove with ectatic pancreatic
ducts in 4 patients, while the other 2 patients had almost
unremarkable MRCP.atients with GP.
ng No. patients %
intense sheet 4 66.6
enal wall thickening with high T2 signal 6 100
dilatation and distal tapering 4 66.6
eatic head enlargement 3 50
eatic duct dilatation 4 66.6
ed enhancement 3 50
enal cysts 4 66.6
ctions and stranded mesentery 0 0
egional lymph nodes 0 0
-abdominal metastasis 0 0
lar invasion 0 0
istension 0 0
Fig. 4. Axial T1VIBE late arterial phase (A) showing ill defined enhancing sheet with cystic changes at the duodeno-pancreatic groove (green arrows).
Delayed phase (B) shows retained contrast enhancement (green arrows). Axial T2W (C) and coronal single shot MRCP (D), showing duodenal wall
thickening and cystic changes (green arrows C&D) at the medial wall of the second part duodenum (hence the name: Cystic Dystrophy of Ectopic Pancreas).
The pancreatic head is enlarged. Segmental form of groove pancreatitis.
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tapering which was regular without shoulder sign or
abrupt interruption of the ducts in cancers.
On MRCP, the distance separating distal pancreatic and
CBD from duodenal lumen is due to inflammatory lesion in
the PD groove and the duodenal wall marked thickening.
This is common in GP and not in pancreatic neoplastic
lesions [25,26].
The main pancreatic duct is usually not dilated in the
pure form of GP, while the segmental form shows stricture
within the pancreatic head that is usually longer than
those associated with pancreatic neoplasms. Also GP
showed milder upstream dilatation of the pancreatic ducts
in the rest of the pancreatic body and tail [27].
None of our cases showed abnormal dilatation of the
GB. The GB tends to be normally distended in GP. Previous
studies described Banana like gallbladder in cases of GP
simulating those seen in traditional chronic pancreatitis
[26].
MRCP is valuable in diagnosis of GP as it yields diagnos-
tic data more or less similar to ERCP. However, in GP, duo-
denal stenosis often hinders ERCP [25]. ERCP is limited to
visualization of a tapered lower bile duct, which can some-times be difficult to differentiate GP smooth long stricture
from irregular strictures in malignancies [13].
The appearance of GP with both transabdominal and
endoscopic ultrasound is not well detailed in the literature.
In the early stages with more inflammatory component, U/
S may show hypoechoic band like thickening of the PD
groove and thickening of the adjacent duodenum with or
without hypoechoic heterogeneous pancreatic head. In
the chronic stages, the echogenicities of all these lesions
become hyper as fibrosis dominates over inflammation
[28]. It is common to visualize regular narrowing of the
CBD and the Santorini duct on endoscopic ultrasound [29].
Fine needle biopsy even those guided by endoscopic US
are challenging to pathologists. The relatively small sample
volume may not be adequate to exclude the presence of
malignant cells [3,16,30]. Even Fibrosis diagnosed by
pathologists does not exclude neoplastic changes. as pan-
creatic adenocarcinoma may show desmoplastic reaction
simulating the fibrotic changes in chronic inflammatory
abnormality such as GP putting down the diagnostic merit
of the Fine needle biopsy in such cases [31,32].
Similar to our results, previous studies reported limited
value of laboratory markers in diagnosis of GP because
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often normal or just minimally elevated. Pancreatic tumor
markers (CEA and CA-19-9) are usually negative in GP.
These negative biomarkers may suggest GP rather than
neoplastic process [6,33].
The most challenging differential diagnosis of GP (espe-
cially its segmental form) is from pancreatic head adeno-
carcinoma and malignancies which arise adjacent to the
PD groove and do not show the typical pancreatic double
duct cutoff and upstream atrophy. The management plans
of the GP and pancreatic cancer two are significantly differ-
ent [6]. This differentiation can be impossible, and many
patients may undergo Whipple procedure because of lack
of this preoperative discrimination [5]. Even more this dif-
ferentiation is important in optimizing therapeutic deci-
sions, including the decision of whether or not to use
preoperative chemotherapy if GP is excluded [34].
Unlike GP, most pancreatic adenocarcinomas do not
show internal cystic change and are much more likely to
infiltrate posteriorly into the retroperitoneum and encase
the vasculature. Moreover, thickening of the medial duode-
nal wall, a common finding with GP, is uncommon with
pancreatic adenocarcinoma. Enhancement pattern for GP
tends to be more patchy and heterogeneous with delayed
contrast retained while pancreatic adenocarcinoma usually
shows more homogeneous hypodensity [25,26].
Kalb et al. [34] reported that contrast-enhanced MR
imaging may help accurately differentiating GP from pan-
creatic cancer when using suggested 3 diagnostic signs
for GP including mural duodenal thickening, delayed
enhancement of the second part of the duodenum; and
cysts seen within duodenal wall or PD groove. They found
correct diagnosis of GP was achieved with accuracy of
87.2% while exclusion of cancer can had a negative predic-
tive value of 92.9%.
The differentiation between GP and scirrhous adenocar-
cinoma invading the groove is difficult on CT and MR imag-
ing. Both produce similar T1 low signal with or without
delayed enhancement [35–37]. However, carcinomas often
have more discrete and round configuration while fibrosis
is more diffuse and ill defined [26]. The presence of vascu-
lar invasion is highly suggestive of pancreatic carcinoma
and not reported in GP [38,35].
Furthermore, it is more difficult to differentiate
between GP and carcinomas arising in the PD groove,
because they may be associated with duodenal mural
thickening and stenosis. Duodenal biopsies may correctly
reach a diagnosis [35].
Differentiating GP from acute pancreatitis is rather easy
due to fluid collections and inflammation in the PD groove
that evolves rapidly on serial follow-up imaging and
should usually resolve later on, whereas the imaging find-
ings associated with GP often persist. Acute edematous
pancreatitis, involves a large portion of the pancreatic par-
enchyma, and not only epicentered in the groove with
peripancreatic fluid and inflammation tracking into the
pararenal spaces, while GP typically shows little retroperi-
toneal inflammation or fluid, and even in the segmental
form, involvement of the pancreas is usually limited to
the pancreatic head. Elevated lipase level is also an impor-
tant differentiating marker [39].Differential diagnosis of GP from chronic pancreatitis
with acute with pseudocysts within the duodenal wall is
rather easy because the later has no mural duodenal thick-
ening or luminal stenosis [40].
Pure form of GP should be differentiated from other
conditions including duodenal cancer as well as distal
CBD and ampullary carcinomas. The later produces focal
malignant lesions at the ampulla, while GP is more ill-
defined crescentic soft tissue, still larger ampullary carci-
nomas may not be easily differentiated from GP on imag-
ing basis [40].
MRCP can help in differentiating GP from cholangiocar-
cinomas involving the CBD, since GP shows a longer
smooth CBD stenosis or tapering compared to the irregular
narrowing, shouldering and abrupt termination of the CBD
in cholangiocarcinomas [40].
Carcinoids and gastrinomas may rarely originate within
the PD groove. These tumors show early hyper-
enhancement due to high vascularity and hyperintense
T2 signal compared to the delayed centripetal enhance-
ment of GP. Duodenal gastrointestinal stromal tumor
(GIST) is more hypodense lesion and still more hyper-
vascular and should not be easily confused with GP [11].
Acute phase of GP is conservatively treated using bed
rest, analgesics and intra-venous nutrition. Most patients
improve with this conservative treatment, but some
patients suffer from relapses of acute pancreatitis espe-
cially those with an anatomic or functional disturbance
of pancreatic duct system [41].
Sometimes GP resists medical treatment and surgical
treatment may be inevitable at late stages of the disease
as the patient may develop marked duodenal stenosis
endocrine and exocrine pancreatic failure, or extensive
fibrotic changes causing severe pain. Those patients
usually benefit from surgery with symptomatic relief
[42,43]. A pancreaticoduodenectomy using the Whipple
procedure or less frequently a pylorus-preserving pancrea-
ticoduodenectomy are the surgical procedures of choice in
groove pancreatitis [6]. Both treatment plans were present
in our cases with satisfactory improvement of the symp-
toms that were noted in 4 out of 6 with conservative man-
agement and 7 out of 10 patients with surgical
management.
Another option was reported as a promising treatment
for GP including ERCP drainage of the duct of Santorini
[44].
Radiological suggestion of the suspicion or suggestion
that a pancreatic head lesion may represent GP should
direct the surgeons for further workup before the decision
of radical surgery. On the other hand, the diagnosis of
groove pancreatitis should not be confirmed until the other
possibility of adenocarcinoma is carefully excluded.
Limitations of our study include retrospective design,
and we limited the scope of our study to describe the imag-
ing features of the documented cases of GP with lack of
comparison with cases of pancreatic head cancer that
may simulate GP. Another limitation is that not all cases
have MRI and MRCP examinations and we did not provide
comparison between CT and MRI.
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GP is a disease that should be considered in the list of
differential diagnosis of masses implicating the pancreatic
head and medial duodenal wall. GP has two types: pure
type that affects exclusively the PD groove and segmental
type which is epicentered in groove with extension medi-
ally into the head of the pancreas. Imaging findings that are
suggestive of GP include chronic inflammatory changes
with fibrosis in the PD groove with or without implication
of the nearby head of the pancreas, duodenal medial mural
thickening with luminal stenosis and cysts at the PD
groove or within the duodenal wall. Vascular invasion is
a sign against diagnosis of GP. Sometime the differentia-
tion between the two forms of GP is not usually clear.Conflict of interest
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